Friday, July 10, 2026
Home Authors Posts by Ogkologos

Ogkologos

4278 POSTS 0 COMMENTS

ESMO Welcomes EU Proposals for MFF & FP10 and Calls for...

Ogkologos -
0

Favourable Results of Patritumab Deruxtecan in Patients with Leptomeningeal Metastatic Disease...

Ogkologos -
0

FDA Approves Neoadjuvant and Adjuvant Pembrolizumab for Resectable Locally Advanced Head...

Ogkologos -
0

EMA Recommends Extending Indications for Durvalumab

Ogkologos -
0

Inaugural ESMO Targeted Anticancer Therapies Asia Congress 2025, Hong Kong SAR,...

Ogkologos -
0

Encouraging Antitumour Activity of First-Line Atezolizumab Plus Paclitaxel and Bevacizumab in...

Ogkologos -
0

Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell...

Ogkologos -
0

Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab...

Ogkologos -
0

FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell...

Ogkologos -
0

EMA Recommends Extension of Indications for Cabozantinib

Ogkologos -
0
1...323334...428Page 33 of 428

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com